These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Effects of botulinum toxin type a on mood and cognitive function in patients with parkinson's disease and depression. Zhu C; Wang K; Yu T; Liu H Am J Transl Res; 2021; 13(4):2717-2723. PubMed ID: 34017433 [TBL] [Abstract][Full Text] [Related]
28. Neuropsychiatric Symptoms in Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation. Liu W; Yamamoto T; Yamanaka Y; Asahina M; Uchiyama T; Hirano S; Shimizu K; Higuchi Y; Kuwabara S Front Neurol; 2021; 12():656041. PubMed ID: 34017303 [No Abstract] [Full Text] [Related]
29. Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies. Li D; McIntosh CS; Mastaglia FL; Wilton SD; Aung-Htut MT Transl Neurodegener; 2021 May; 10(1):16. PubMed ID: 34016162 [TBL] [Abstract][Full Text] [Related]
30. Myricetin prevents high molecular weight Aβ Kimura AM; Tsuji M; Yasumoto T; Mori Y; Oguchi T; Tsuji Y; Umino M; Umino A; Nishikawa T; Nakamura S; Inoue T; Kiuchi Y; Yamada M; Teplow DB; Ono K Free Radic Biol Med; 2021 Aug; 171():232-244. PubMed ID: 34015458 [TBL] [Abstract][Full Text] [Related]
31. Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in Zhang T; Sun B; Zhong C; Xu K; Wang Z; Hofman P; Nagano T; Legras A; Breadner D; Ricciuti B; Divisi D; Schmid RA; Peng RW; Yang H; Yao F Transl Lung Cancer Res; 2021 Apr; 10(4):1857-1872. PubMed ID: 34012798 [TBL] [Abstract][Full Text] [Related]
32. Neuroprotective Effect of Low-Intensity Pulsed Ultrasound on the Mouse MPTP/MPP Chen X; Wang D; Zhang L; Yao H; Zhu H; Zhao N; Peng X; Yang K Ultrasound Med Biol; 2021 Aug; 47(8):2321-2330. PubMed ID: 34011450 [TBL] [Abstract][Full Text] [Related]
33. Pinocembrin-7-Methylether Protects SH-SY5Y Cells Against 6-Hydroxydopamine-Induced Neurotoxicity via Modulating Nrf2 Induction Through AKT and ERK Pathways. Zou ZC; Fu JJ; Dang YY; Zhang Q; Wang XF; Chen HB; Jia XJ; Lee SM; Li CW Neurotox Res; 2021 Aug; 39(4):1323-1337. PubMed ID: 33999357 [TBL] [Abstract][Full Text] [Related]
34. Protective effect of caffeine and/or taurine on the 6-hydroxydopamine-induced rat model of Parkinson's disease: Behavioral and neurochemical evidence. Abuirmeileh AN; Abuhamdah SM; Ashraf A; Alzoubi KH Restor Neurol Neurosci; 2021; 39(2):149-157. PubMed ID: 33998560 [TBL] [Abstract][Full Text] [Related]
35. Decoupling of Global Brain Activity and Cerebrospinal Fluid Flow in Parkinson's Disease Cognitive Decline. Han F; Brown GL; Zhu Y; Belkin-Rosen AE; Lewis MM; Du G; Gu Y; Eslinger PJ; Mailman RB; Huang X; Liu X Mov Disord; 2021 Sep; 36(9):2066-2076. PubMed ID: 33998068 [TBL] [Abstract][Full Text] [Related]
36. Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. Luis G; Godfroid A; Nishiumi S; Cimino J; Blacher S; Maquoi E; Wery C; Collignon A; Longuespée R; Montero-Ruiz L; Dassoul I; Maloujahmoum N; Pottier C; Mazzucchelli G; Depauw E; Bellahcène A; Yoshida M; Noel A; Sounni NE Redox Biol; 2021 Jul; 43():102006. PubMed ID: 34030117 [TBL] [Abstract][Full Text] [Related]
37. Cardiovascular dysautonomia and cognition in Parkinson's Disease - a possible relationship. Kwaśniak-Butowska M; Dulski J; Pierzchlińska A; Białecka M; Wieczorek D; Sławek J Neurol Neurochir Pol; 2021; 55(6):525-535. PubMed ID: 34037978 [TBL] [Abstract][Full Text] [Related]
38. Naturally Occurring Parkinson's Disease Raises the Need for Nonhuman Primates in Neurodegenerative Diseases Research. Yao Y; Dai J Neurosci Bull; 2021 Aug; 37(8):1267-1269. PubMed ID: 34037946 [No Abstract] [Full Text] [Related]
39. A critical role for GM1 ganglioside in the pathophysiology and potential treatment of Parkinson's disease. Schneider JS Glycoconj J; 2022 Feb; 39(1):13-26. PubMed ID: 34037912 [TBL] [Abstract][Full Text] [Related]
40. New Horizons in the Treatment of Neurological Disorders with Tailorable Gold Nanoparticles. Farheen ; Khan MA; Ashraf GM; Bilgrami AL; Rizvi MMA Curr Drug Metab; 2021; 22(12):931-938. PubMed ID: 34036910 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]